Retatrutide continues to be investigational as of 2026. It is not FDA-authorized and can't be prescribed or compounded beyond clinical demo participation.Maximum weight reduction in trials up to now. Glucagon agonism preserves Electrical power expenditure and lean mass. Not offered outside m